Back to blog
|Nelson Marques, MS, RD, LD

Vitamin D Status Workup in Athletes: 25-OH-D Interpretation, Seasonal Variability, Skin-Pigment and Latitude Adjustments, and the Repletion Protocol

A 25-hydroxyvitamin D of 24 ng/mL in a Florida road cyclist in August is one case. The same number in a Chicago indoor wrestler in February is a different case entirely. The sports-RD reads them the same way most of the time, prescribes 2,000 IU per day, rechecks at 12 weeks, and watches the number creep up by 4 ng/mL — short of clinical sufficiency, short of the performance and bone-recovery range, short of what the athlete actually needed. The vitamin D workup that catches the real cases reads against season, latitude, skin pigment, body composition, training environment, and the iron / calcium / magnesium co-dependencies the standard lab panel does not flag. Here is the structured 25-OH-D interpretation protocol for the sports-nutrition intake, the dose-response math that drives the repletion plan, and the SOAP documentation that gets the case co-managed correctly.

ClinicalVitamin DBloodworkRD PracticeRepletion

A 27-year-old NCAA Division I gymnast walks into intake six weeks after a tibial stress fracture. She is in the protected-loading phase of a return-to-sport plan, working with her athletic trainer on a tapered weight-bearing progression. Her sports-medicine physician ran a bone-health panel as part of the workup. Calcium is 9.6 mg/dL. Phosphorus is 3.8 mg/dL. PTH is 38 pg/mL. 25-hydroxyvitamin D is 22 ng/mL. The note in the chart reads "vitamin D insufficient, recommend supplementation." She has been on 1,000 IU per day of an over-the-counter D3 capsule for four weeks. She is asking whether the dose is right and whether her vitamin D status has anything to do with the fracture in the first place.

The 1,000 IU per day she is taking will, on the population-average dose-response curve, raise her serum 25-OH-D by roughly 8 to 10 ng/mL over 8 to 12 weeks. That brings her from 22 to a projected 30 to 32 ng/mL at the next recheck. The Endocrine Society sufficiency threshold is 30 ng/mL. The Institute of Medicine threshold is 20 ng/mL. The athletic-performance and bone-recovery literature consistently cites a higher target — 40 to 50 ng/mL, with some bone-health and stress-fracture-recovery protocols pushing the target to 50 to 60 ng/mL. The athlete's current dose will move her into the conservative-sufficiency range and stop. The dose that lands her in the bone-recovery range is two to four times what she is taking. The chart note that triggered the prescription did not specify the target, did not specify the dose-response math, and did not specify a recheck cadence calibrated to the fracture-recovery timeline. The athlete is going to spend the next eight weeks of her return-to-sport on a sub-target vitamin D status because the workup was a single label ("insufficient") and a single dose ("supplementation").

Most sports-RD intakes do not run a structured vitamin D workup. The 25-OH-D arrives from primary care, the lab flag (insufficient / deficient / sufficient) is the headline, and the supplement recommendation defaults to 1,000 to 2,000 IU per day with a recheck in 3 to 6 months. The interpretive frame that turns the single lab value into a calibrated repletion plan — season at draw, latitude, skin pigment, BMI, training environment, iron status, calcium and magnesium adequacy, and the performance-range target rather than the population-sufficiency threshold — is rarely on the worksheet. The athlete who needed 5,000 IU per day for 12 weeks to land at 50 ng/mL ends up on 1,000 IU per day for 24 weeks and lands at 32, which is where the chart note will say "sufficient" and the workup closes — at a value where the bone, immune, and muscle-function literature says the recovery and performance signals are still incomplete.

This post is the vitamin D workup I run when a 25-OH-D shows up in the sports-nutrition intake. The six-dimension interpretive frame, the dose-response math that drives the repletion plan, the iron / calcium / magnesium co-dependencies, the medical-coordination triggers, the common counseling mistakes, and the SOAP pattern that documents the case defensibly.

Why a single 25-OH-D number is the wrong instrument

Three structural reasons.

The reference range was calibrated on bone-health endpoints in a sedentary, mixed-pigment, geographically mixed population. The Institute of Medicine set 20 ng/mL as the lower bound for bone-mineralization adequacy in the general population. The Endocrine Society set 30 ng/mL as the lower bound for clinical sufficiency. Neither range was calibrated on athlete-specific endpoints: stress-fracture recovery, muscle function (the vitamin D receptor is expressed on skeletal myocytes), immune function during heavy training, or insulin sensitivity. The athletic-performance and bone-recovery literature consistently lands on a higher target range — 40 to 50 ng/mL — and the stress-fracture-recovery and overtraining-recovery literature lands higher still. A 25-OH-D of 28 in an injured female runner is flagged "sufficient" by the bone-population reference range and is substantially under-target for her injury-recovery physiology.

The same number means different things across season, latitude, and pigment. A 25-OH-D of 30 ng/mL in a fair-skinned athlete in Miami in September is a different signal than a 25-OH-D of 30 ng/mL in a dark-skinned athlete in Minneapolis in February. The first athlete is in her annual peak and will fall through winter; the second athlete is at her annual nadir and has nowhere lower to go. The same lab number describes two different trajectories. The intake that reads the number in isolation, without the seasonal and geographic context, misses the trajectory entirely.

The clinical action is multi-factor and the standard prescription is single-factor. Vitamin D status interacts with calcium adequacy (the D-PTH-calcium axis cannot be calibrated from D alone), magnesium adequacy (magnesium is a co-factor for the 25-hydroxylase and 1-alpha-hydroxylase enzymes that convert D3 to its active forms — a magnesium-deficient athlete on 5,000 IU per day will under-respond), iron status (the iron-D interaction in the female-athlete population is well-described and the [iron-status workup](/blog/iron-status-workup-in-female-athletes) should run in parallel), and body composition (D3 is fat-soluble and BMI is the strongest single predictor of the dose-response slope — higher fat mass dilutes the same oral dose). The single-prescription approach hits one lever in a multi-lever system.

The six-dimension vitamin D workup

Dimension 1: 25-OH-D against the athletic-target range. Read the number against 40 to 50 ng/mL as the working target for in-season athletes, 50 to 60 ng/mL for athletes in stress-fracture recovery or with documented frequent upper-respiratory infections, and the standard 30 to 40 ng/mL as the floor for off-season general health. A draw of 28 in an injured athlete is a repletion case even though the lab flag reads "sufficient." A draw of 45 in a healthy in-season athlete is on-target and warrants seasonal monitoring rather than dose escalation.

Dimension 2: Season and latitude at draw. Cutaneous D3 synthesis from UVB requires a solar zenith angle below roughly 50 degrees, which constrains the season-and-latitude combinations in which the athlete can produce any meaningful D3 from sun exposure at all. Above roughly 35 degrees north latitude (Memphis, TN and northward) the synthesis season runs roughly April to October; above 42 degrees (Boston, Chicago, Detroit, Portland, Minneapolis) the synthesis season collapses to roughly May to September; above 50 degrees (Calgary, parts of the UK) the synthesis season is functionally absent. A draw taken in February at latitude 42 is at the athlete's annual nadir; the same athlete drawn in September is at her annual peak. Document the season and latitude at draw, and project the seasonal trajectory before setting the repletion dose.

Dimension 3: Skin pigment. Melanin is a UVB filter. Fair-skinned (Fitzpatrick I-II) athletes synthesize cutaneous D3 at roughly 6 to 10 times the rate of dark-skinned (Fitzpatrick V-VI) athletes for the same UVB exposure. The athletic-population cohort data consistently shows higher prevalence of insufficiency and deficiency in athletes with Fitzpatrick IV-VI pigmentation, with the gap widening at northern latitudes and during indoor-training seasons. Document pigment by Fitzpatrick category and read the lab value against the pigment-adjusted dose-response curve.

Dimension 4: Body composition and BMI. Vitamin D3 partitions into adipose tissue. Across the dose-response literature, BMI is the strongest single predictor of the per-IU response slope: athletes with BMI in the 18-25 range typically raise serum 25-OH-D by roughly 0.7 to 1.0 ng/mL per 100 IU per day over 8 to 12 weeks; athletes with BMI in the 25-30 range respond at roughly 0.5 to 0.7 ng/mL per 100 IU per day; athletes with BMI in the 30-plus range respond at roughly 0.3 to 0.5 ng/mL per 100 IU per day. The same 2,000 IU per day dose lands a 60-kg female runner near sufficiency and lands a 105-kg offensive lineman well short. Read BMI before setting the repletion dose.

Dimension 5: Training environment. Indoor athletes (gymnasts, swimmers, wrestlers, ice hockey players, indoor track athletes, weightlifters with most training under fluorescent fieldhouse lighting) functionally do not get cutaneous D3 synthesis from training and depend on diet and supplementation. Outdoor-during-synthesis-season athletes (road cyclists, track athletes, soccer players in summer training) often run higher serum 25-OH-D peaks but are subject to the same winter nadir as everyone else. Document training environment and seasonality of outdoor exposure; the indoor-sport athlete in any season is functionally a winter athlete from a D-synthesis perspective.

Dimension 6: Co-factor and co-dependency status. Magnesium adequacy (RDA 310-420 mg/day; serum magnesium is a poor marker but dietary recall plus symptom screen identifies the deficient majority), calcium adequacy (1,000-1,300 mg/day depending on age and sex, with the [bone density workup](/blog/bone-mineral-density-workup-sports-dietetics) integrated for at-risk athletes), iron status (parallel [iron workup](/blog/iron-status-workup-in-female-athletes) for any female athlete and any athlete with declining performance), and vitamin K2 adequacy (under-studied but the D-K2-calcium-bone axis is biologically coherent and the cost of dietary K2 adequacy is near-zero). The repletion plan that addresses D in isolation under-performs the plan that addresses the multi-nutrient system.

The dose-response math

The repletion plan is arithmetic, not vibes. Three numbers drive it.

Current 25-OH-D from the lab draw. The starting point.

Target 25-OH-D from the dimension-1 reading. The endpoint — typically 50 ng/mL for in-season athletes, 60 for stress-fracture recovery, 40 for off-season general health.

Per-IU response slope adjusted for BMI. From the dimension-4 reading — typically 0.7-1.0 ng/mL per 100 IU per day for BMI under 25, 0.5-0.7 for BMI 25-30, 0.3-0.5 for BMI over 30, with downward adjustment for dark pigment, indoor training environment, and northern-latitude winter (these stack — a dark-pigment athlete at BMI 28 indoor-training in February in Minneapolis sits at the low end of the slope range with a population-adjustment downward bias).

The maintenance-plus-repletion dose is the per-IU slope projected backward from the (target - current) gap, scaled to a 12-week timeline. A 70-kg female track athlete (BMI 22) drawn at 28 ng/mL in March, target 50 ng/mL, projected slope 0.9 ng/mL per 100 IU per day: gap of 22 ng/mL, dose of roughly 2,400 IU per day for 12 weeks, then recheck. A 110-kg offensive lineman (BMI 31) drawn at 18 ng/mL in February in Buffalo, target 50, projected slope 0.4 ng/mL per 100 IU per day: gap of 32 ng/mL, dose of roughly 8,000 IU per day for 12 weeks, then recheck. The two cases do not get the same prescription. The cookbook 2,000 IU per day gets neither athlete to target.

Tolerable upper intake. The IOM upper limit is 4,000 IU per day for adults; the Endocrine Society treatment guideline tolerates 10,000 IU per day under monitoring in deficient adults. Doses above 4,000 IU per day should be paired with a recheck at 8-12 weeks rather than the standard 3-6 months, and should not be sustained beyond the documented repletion window without re-evaluation. Doses above 10,000 IU per day belong in the endocrinology lane, not the sports-RD lane.

Loading-dose protocols (50,000 IU per week for 8-12 weeks) are an alternative repletion pathway used in clinical hypoparathyroid and severe-deficiency contexts. They are not the default for sports-RD repletion and should be reserved for the deficient case (under 20 ng/mL) co-managed with the athlete's primary care or endocrinology.

The four-quadrant decision matrix

The six dimensions collapse into a four-quadrant matrix that drives the action plan.

Quadrant 1: 25-OH-D at or above 40, no recent injury, healthy in-season athlete. On-target. Maintain current diet and supplementation. Seasonal monitoring — recheck at the next opposite-season touchpoint (athletes drawn at peak get a winter-nadir recheck; athletes drawn at nadir get a summer-peak recheck) to map the annual range.

Quadrant 2: 25-OH-D 30-40, no recent injury, healthy athlete. Conservative-sufficiency range, below athletic-performance target. Modest repletion — typically 1,500-3,000 IU per day for 12 weeks calibrated to BMI and pigment — with recheck at 12 weeks and integration of the calcium-magnesium-iron co-factor workup.

Quadrant 3: 25-OH-D 20-30, or any value with active injury or recurring infections. Repletion case. Calibrated dose per the dose-response math, paired with calcium and magnesium adequacy screen, iron workup if female athlete or performance-declining, and bone-density workup integration for any stress-fracture or fragility-fracture history. Recheck at 8-12 weeks rather than the standard 3-6 months. Coordinate with the athlete's primary care for the recheck and for any concurrent medications that affect D metabolism (anticonvulsants, glucocorticoids, certain antiretrovirals).

Quadrant 4: 25-OH-D below 20. Deficiency. Refer to primary care for co-management. The sports-RD repletion plan runs in parallel with the medical workup — calibrated high-dose repletion (4,000-10,000 IU per day or a loading protocol per medical guidance), recheck at 8 weeks, integrated calcium-magnesium-iron workup, and consideration of the differential causes (malabsorption, granulomatous disease, hereditary forms) that warrant endocrinology evaluation in the case that fails to respond to standard repletion.

When to refer to medical

Five signals warrant medical referral beyond the dietetic repletion plan.

25-OH-D below 12 ng/mL on any draw. Severe deficiency. Endocrine or primary-care co-management regardless of clinical picture.

Failure to respond to a calibrated 12-week repletion plan. A 12-week dose at the calculated per-IU slope that produces less than half the projected rise points to malabsorption (celiac, IBD, prior bariatric surgery), a co-factor deficiency that was not addressed (magnesium), a medication interaction, or a hereditary variant in the D-binding-protein or receptor pathway. Refer for the differential workup.

Hypercalcemia at recheck. Serum calcium above the reference range during high-dose repletion is the rare but real toxicity flag. Stop supplementation immediately and refer for endocrine workup; sarcoidosis, lymphoma, and primary hyperparathyroidism are the differential triggers.

PTH elevation despite repletion. Persistent PTH above the reference upper limit in an athlete whose 25-OH-D has been brought into range warrants endocrine evaluation for primary or secondary hyperparathyroidism.

Recurrent stress fractures despite an apparently adequate workup. Vitamin D status is one variable in the stress-fracture differential; the case that recurs despite calibrated D repletion warrants the integrated bone-density, energy-availability ([LEA screening](/blog/screening-athletes-for-low-energy-availability)), iron, menstrual-status, and biomechanical workup that sports medicine and endocrinology co-manage.

Common counseling mistakes

Reading the lab flag at face value. "Sufficient" at 30 ng/mL is the bone-population threshold, not the athletic-performance target. The sports-RD interpretation reads against the higher athletic-target range.

Prescribing the cookbook 2,000 IU per day without the dose-response math. The same dose lands different athletes at different endpoints. The repletion plan is calculated, not defaulted.

Counseling D3 in isolation without the magnesium-calcium-iron co-factor workup. A magnesium-deficient athlete will under-respond to D supplementation. A calcium-inadequate athlete loses much of the bone-mineralization benefit. A female athlete with iron deficiency has a parallel performance differential that the D workup does not address.

Counseling sun exposure as the primary repletion lever in the wrong season or pigment context. "Get more sun" is not a meaningful repletion plan for an indoor-training athlete in February at latitude 42, for a Fitzpatrick V-VI athlete at any latitude, or for an athlete with sun-sensitive medications. The dietary-plus-supplementation repletion plan does the work; sun exposure is supplemental at best for the populations that need repletion most.

Skipping the seasonal recheck. The summer-peak draw and winter-nadir draw on the same athlete frequently differ by 15-25 ng/mL. The intake that reads a single draw without the seasonal-trajectory frame misses the case where the athlete is on-target in August and deficient in February on the same supplementation plan.

Counseling vitamin D2 (ergocalciferol) when D3 (cholecalciferol) is the better form. D3 is more efficient at raising serum 25-OH-D per unit dose and has a longer serum half-life. D2 is the prescription form (50,000 IU weekly capsules) and is appropriate in the loading-dose pathway under medical guidance; D3 is the better default for the dietetic over-the-counter repletion plan.

Failing to coordinate with the athlete's primary care and sports medicine. Vitamin D status interacts with bone health, infection susceptibility, and stress-fracture recovery — all surfaces where sports medicine has a clinical interest. The chart trail has to show the coordination.

Where this lands in the SOAP

Subjective section format:

```

Vitamin D Workup (panel reviewed YYYY-MM-DD):

  • 25-OH-D: [X ng/mL, lab reference range, draw date]
  • Serum calcium: [X mg/dL, lab reference range]
  • PTH: [X pg/mL, lab reference range, or NOT ORDERED]
  • Serum phosphorus: [X mg/dL, lab reference range, or NOT ORDERED]
  • Magnesium: [serum X mg/dL OR dietary recall, OR NOT ASSESSED]
  • Calcium intake: [X mg/day from food and supplementation]

Athletic-physiology context:

  • Season at draw: [month, latitude of training city]
  • Skin pigment: [Fitzpatrick I-VI]
  • BMI: [X, body-composition method if available]
  • Training environment: [indoor / outdoor, season]
  • Injury status: [active / recent / clear]
  • URI history: [frequency past 12 months]
  • Iron status: [parallel workup result or NOT YET RUN]
  • Menstrual status: [if applicable]

Quadrant: [1-4 from clinical matrix]

Projected per-IU response slope: [X ng/mL per 100 IU/day]

Target 25-OH-D: [X ng/mL]

Gap: [target - current = X ng/mL]

Calculated repletion dose: [X IU/day for X weeks]

Medical red flags: [list or "none identified"]

Co-factor adequacy: [calcium / magnesium / iron status notes]

Clinical impression: [statement integrating panel with athletic physiology]

Action: [calibrated repletion / seasonal-recheck-only / medical referral / integrated workup expansion]

Follow-up: [recheck date, plan]

```

Assessment integrates the D panel with the calcium-magnesium-iron co-factor status, the seasonal and geographic context, the training environment, and the symptomatic and injury picture. Plan documents the dose-response math that drove the prescription, the recheck cadence, and any medical-coordination communications. See [SOAP notes for sports dietitians](/blog/soap-notes-for-sports-dietitians) for the broader documentation framework.

The female-athlete vitamin D thread

Female athletes carry a disproportionate share of the stress-fracture and bone-stress-injury burden in endurance and aesthetic sports, and the vitamin D workup is one of three parallel workups that should run on any female athlete presenting with bone-stress injury, RED-S indicators, or persistent fatigue. The other two are the [iron-status workup](/blog/iron-status-workup-in-female-athletes) and the [menstrual-cycle and contraceptive-status workup](/blog/menstrual-cycle-charting-in-female-athlete-intake). Reading any one in isolation misses the cases where the dominant driver is in a parallel system. The integrated workup catches the multi-driver presentation that the single-panel read does not.

The masters-athlete vitamin D trajectory

Masters athletes (typically 50-plus) carry rising baseline prevalence of vitamin D insufficiency for the same reasons the general population does at that age — declining cutaneous synthesis efficiency, lower outdoor exposure in many lifestyles, higher prevalence of medications that affect D metabolism — overlaid on the athletic-population frame. The masters athlete drawn at 28 ng/mL in February is closer to the population pattern than to the young-elite-athlete pattern, and the repletion plan typically runs longer and at slightly higher maintenance doses than the young-athlete equivalent. Integrate with the bone-density workup and the cardiovascular-medications screen routinely in this population.

Where platform tooling helps

The bottleneck in the vitamin D workup at scale is the multi-dimensional interpretation — the lab value read against season, latitude, pigment, BMI, training environment, and co-factor status, the dose-response math calibrated per-athlete, the multi-nutrient repletion plan tracked across calcium-magnesium-iron-K2, the recheck cadence held against the repletion timeline rather than a calendar default, and the medical-coordination communications logged across the care team. The intake that does all of this by hand drops the integration on busy weeks and the case surfaces months later with the athlete still under-target on the same cookbook 2,000 IU per day.

The leverage is a vitamin D workup module that ingests the panel values, reads season and latitude from the athlete's training location, captures pigment and BMI, projects the per-IU response slope, calculates the calibrated repletion dose, integrates the calcium-magnesium-iron workups, tracks recheck cadence against the repletion timeline, pre-populates the SOAP documentation, and surfaces the medical-coordination communications. The RD's job becomes the clinical judgment and the conversation, not the arithmetic.

The chart trail is also defensible — every dose tied to the math that produced it, every co-factor workup tied to the integration logic, every medical referral documented with the workup data that justified it.

The bottom line

Vitamin D status in athletes is a multi-dimensional read, not a single-number label. The reference range was calibrated on a different population and a different endpoint than the sports-RD case demands. The same lab number means different things across season, latitude, pigment, BMI, training environment, and co-factor status. The cookbook 2,000 IU per day under-doses the high-BMI, dark-pigment, indoor-training, northern-latitude athlete and over-shoots the off-season healthy athlete who needed a maintenance plan rather than a repletion plan. The workup that catches the real cases reads the lab value across all six dimensions, calibrates the dose to the BMI-adjusted per-IU response slope, integrates the calcium-magnesium-iron co-factor workups, holds the recheck cadence against the repletion timeline, and coordinates with the medical team on the cases that warrant the differential workup.

The 27-year-old gymnast with a 22 ng/mL draw and a healing tibial stress fracture is not a 1,000-IU-per-day case. She is a calculated-repletion case targeting 50-60 ng/mL across a 12-week window paired with calcium adequacy, magnesium adequacy, parallel iron workup, integrated bone-density workup, and recheck cadence calibrated to her return-to-sport timeline. The intake that runs the structured workup catches this. The intake that reads the lab flag and prescribes the cookbook dose does not.

[Calsanova's Dietitian plan](/signup?role=dietitian) ships a vitamin D workup module with panel-value ingestion, season-latitude-pigment-BMI interpretation, dose-response math for calibrated repletion, integrated calcium-magnesium-iron co-factor workups, recheck-cadence management against the repletion timeline, and pre-populated SOAP documentation. Start your 30-day free trial and turn the 25-OH-D panel from a single-number label into a clinical instrument that catches the cases the cookbook prescription misses.

Ready to modernize your practice?

Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.

Start your free trial

Get more like this.

Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.

Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson

More from the Classroom

hs-CRP Interpretation in Athletes: Why the Cardiovascular-Risk Reference Range Misreads Training-Driven Elevations, the Ferritin and Iron-Status Cross-Talk the Intake Must Integrate, and the Post-Session Draw-Timing Correction That Separates the Real Cases

A 32-year-old marathon runner arrives at intake with an hs-CRP flagged at 4.8 mg/L on a routine cardiovascular-risk panel, a primary-care recommendation to begin statin therapy for 'elevated cardiovascular inflammation,' and a training week averaging 68 miles across 6 to 7 sessions with a 22-mile long run 36 hours before the draw. The standard hs-CRP interpretation was calibrated in the AHA/CDC cardiovascular-risk-stratification framework — below 1.0 mg/L low risk, 1.0 to 3.0 mg/L average risk, above 3.0 mg/L high risk — using populations dominated by metabolic-syndrome-associated inflammation, and it misclassifies a substantial fraction of the trained-endurance-athlete cases where the elevation is a training-load-driven acute-phase response that resolves off the training window. Reading hs-CRP in isolation misses this case. Here is the structured hs-CRP workup for the sports-nutrition intake: the six-dimension interpretive frame, the acute-vs-chronic draw-timing correction, the ferritin and iron-status cross-talk (hs-CRP is an acute-phase modifier of the iron read), the metabolic-syndrome and body-composition overlay, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the statin-referral read.

August 4, 2026

Creatine Kinase Interpretation in Athletes: Why the Standard Lab Reference Range Misreads Post-Training CK, the Rhabdomyolysis Differential the Sports RD Must Own, and the Weekly-Trending Protocol That Beats a Single Draw

A 24-year-old collegiate rowing coxswain-turned-CrossFit competitor walks into intake with a lab printout that flagged her serum creatine kinase at 4,820 U/L six days after an unaccustomed 40-minute AMRAP that hit her posterior chain hard. Her primary-care nurse practitioner called her to say she was 'in acute kidney failure territory' and told her to go to the emergency department. She went, spent nine hours in observation getting a saline drip and repeat labs, was discharged on 'no exercise for two weeks,' and lost her spot in the qualifier that Saturday. Her second CK draw at the ED — 22 hours after the first — had already dropped to 2,150 U/L. Her creatinine was 0.8 mg/dL throughout. Her urine dipstick was clear for myoglobin. She was, on any reasonable read, a healthy athlete inside a normal post-eccentric CK excursion, misidentified as an incipient rhabdomyolysis on the strength of a single draw compared against a sedentary reference range. The standard laboratory CK reference — usually cited as 30-200 U/L for females and 55-370 U/L for males — was calibrated on adults who did not train. A single post-heavy-training CK draw in an athlete without the ascending-CK, symptom, urine, and renal context tells you almost nothing about muscle injury and much less about kidney risk. Here is the structured CK workup the sports RD should run when a CK value surfaces in the intake or a mid-camp panel: the exercise-induced CK curve, the ULN reset against the athlete population, the rhabdomyolysis-versus-normal-adaptation differential, the weekly-trending protocol that replaces the single-draw misread, the co-management triggers to the sports-medicine physician, and the SOAP pattern that documents the clearance defensibly.

July 23, 2026

Uric Acid Interpretation in Athletes: Why the High-Protein and High-Fructose Sports-Nutrition Diet Confounds the Standard Read, the Renal-vs-Metabolic Differential, and the Purine-Load Audit the Intake Must Run

A 34-year-old ultramarathon runner arrives at intake with a serum uric acid of 8.9 mg/dL flagged as 'hyperuricemia' on a routine metabolic panel, a primary-care referral to a rheumatologist for suspected gout despite no joint symptoms, and a nutrition history dominated by a self-directed high-protein endurance diet, a race-week carbohydrate load leaning on fructose-rich sports drinks, and a training-day sweat rate the workup did not capture. The standard uric acid interpretation was calibrated against a sedentary reference population and misses the athletic case where the elevation runs through a purine-load overlay, a sweat-driven concentration artifact, a fructose-driven hepatic de novo synthesis pathway, and (in a subset of cases) a genuine renal or metabolic disorder the panel is finally surfacing. Reading uric acid in isolation misses this case. Here is the structured uric acid workup for the sports-nutrition intake: the five-dimension interpretive frame, the purine-load audit against the protein and organ-meat pattern, the fructose-load overlay that separates the sports-drink and race-week driver, the sweat-concentration correction the endurance intake must run, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the rheumatology referral.

July 16, 2026